To put things in perspective: * We have an appl
Post# of 15624
* We have an application for full IP . Less than handful applications for full IP had been filed for MMJ products
* we have pre-clinical efficacy study results that , to those that understand, are scientific breakthrough
* we have the first ever IRB approval for MMJ cream
* we have developed a unique sub-lingual tablet
* we have a MM study
And much more which part is public domain and most is still not I believe
Management:
Our CSO is the former Israeli MMJ regulator . It will take many years to match his knowledge
Our CEO , chaired the biggest investment house in Israel and sat in the BOD of 2 successful biotech companies ( in fact he lead one Dr. Hirsch's previous exits ...)
Our CFO - left a Nasdaq company to Join OWCP ....
Our Chairman with PHD from oxford ...
Scientific & managerial expertise- directly related to our business
Advisory board , Dr. Rosenblatt, Mrs. Miri Sani = A Team
Show me one MMJ OTC company with fraction of what we have ....and all that in 3 years of operations